Login to Your Account

Wuxi-manufactured IMP321 becomes first China-made biologic dosed in EU trial

By Pearl Liu
Staff Writer

Thursday, March 3, 2016

HONG KONG – China's Wuxi Biologics Co. Ltd. managed a breakthrough by getting a biological product it manufactures approved in the use of clinical trials in Belgium, making it the first-ever China-made biologic dosed in a clinical trial in the European Union.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription